Last reviewed · How we verify
Randomized Cross-over Trial in Patients Treated With Both Insulin & Hydrocortisone (INSCORT)
The aim of INS.CORT trial is, by studying glycemic variability in a well-defined patient group with both insulin \& hydrocortisone (patients with concomitant insulin-treated diabetes \& Addison's disease) and collecting information about the administration -time point and doses- of insulin, hydrocortisone and food intake with the help of new technology to improve the treatment in all patients treated with both insulin \& glucocorticoids.
Details
| Lead sponsor | Vastra Gotaland Region |
|---|---|
| Phase | NA |
| Status | NOT_YET_RECRUITING |
| Enrolment | 16 |
| Start date | 2024-09 |
| Completion | 2027-12 |
Conditions
- Diabetes Mellitus
- Adrenal Insufficiency
- Polyglandular Autoimmune Syndrome
Interventions
- OD dual-release Hydrocortisone
- TID Hydrocortisone
Primary outcomes
- glycemic variability — 4 weeks
glycemic variability
Countries
Sweden